(19)
(11) EP 0 800 534 A2

(12)

(43) Date of publication:
15.10.1997 Bulletin 1997/42

(21) Application number: 95942207.0

(22) Date of filing: 27.12.1995
(51) International Patent Classification (IPC): 
C12N 5/ 10( . )
A61K 38/ 17( . )
A61P 1/ 00( . )
A61P 9/ 10( . )
A61P 25/ 00( . )
A61P 31/ 12( . )
A61P 37/ 00( . )
C07K 14/ 705( . )
C07K 16/ 28( . )
 A61K 38/ 00( . )
A61K 39/ 395( . )
A61P 3/ 08( . )
A61P 17/ 00( . )
A61P 29/ 00( . )
A61P 35/ 00( . )
A61P 37/ 08( . )
C07K 14/ 74( . )
A61K 39/ 385( . )
(86) International application number:
PCT/EP1995/005164
(87) International publication number:
WO 1996/020215 (04.07.1996 Gazette 1996/30)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
SI

(30) Priority: 23.12.1994 EP 19940203755

(71) Applicants:
  • LABORATOIRES OM S.A.
    1217 Meyrin 2 (CH)
  • DEUTSCHE OM ARZNEIMITTEL GmbH
    61381 Friedrichsdorf/Ts. (DE)

(72) Inventor:
  • LAUENER, Roger Pascal
    8128 Hinteregg (CH)

(74) Representative: Van Someren, Petronella F. H. M., et al 
Arnold & Siedsma, Advocaten en Octrooigemachtigden, Sweelinckplein 1
2517 GK Den Haag
2517 GK Den Haag (NL)

   


(54) USE OF MHC-II BINDING AND/OR MHC-II MIMICKING MOLECULES FOR THE PREVENTION AND/OR TREATMENT OF INFLAMMATORY DISEASES